Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04844359 · ClinicalTrials.gov registry record
A Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis
A clinical trial of Hypersensitivity Pneumonitis, sponsored by National Jewish Health.
- Active
- Registry status
- 137
- Enrollment target
- 7
- Study locations
NCT04844359 is a study of Hypersensitivity Pneumonitis that is active but no longer recruiting, run by National Jewish Health. The registered enrollment target is 137 participants, below the 357-participant average among 3 other Hypersensitivity Pneumonitis trials with a reported enrollment target (62% lower). The trial reports 7 study locations across 7 states.
The verdict
NCT04844359, a study of Hypersensitivity Pneumonitis, is active but no longer recruiting, sponsored by National Jewish Health.
- ACTIVE NOT RECRUITING
- Registry status
- 137 participants
- Enrollment target
- 7
- Study locations
Study Summary
Up to 150 patients with hypersensitivity pneumonitis will be enrolled at 7 clinical centers across the United States. Patients will be followed for 24 months to determine if biomarkers in the blood can predict disease progression.
Conditions Studied
Study Locations (7)
Arizona
- University of Arizona - Tucson
California
- University of California Davis - Sacramento
Colorado
- National Jewish Health - Denver
Illinois
- University of Chicago - Chicago
Minnesota
- Mayo Clinic - Rochester
Texas
- University of Texas Southwestern - Dallas
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2021-01-06 |
| Est. Completion | 2025-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04844359
The ClinicalTrials.gov registry entry for NCT04844359 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 357-participant average among 3 other Hypersensitivity Pneumonitis trials with a reported enrollment target (62% lower). The listed sponsor is National Jewish Health, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypersensitivity Pneumonitis appearing as the primary indexed condition, and to 0 interventions.
NCT04844359 reports 7 study locations spanning 7 distinct geographic areas - top geographies include Arizona, California, Colorado.
Frequently Asked Questions
What is clinical trial NCT04844359 about?
NCT04844359 is a clinical study titled "A Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis". Up to 150 patients with hypersensitivity pneumonitis will be enrolled at 7 clinical centers across the United States. Patients will be followed for 24 months to determine if biomarkers in the blood can predict disease progression.
What is the current status of trial NCT04844359?
This trial is currently active not recruiting. The enrollment target is 137 participants. The study started on 2021-01-06. Estimated completion is 2025-07-31.
What conditions does trial NCT04844359 study?
This clinical trial studies the following conditions: Hypersensitivity Pneumonitis.
Who is sponsoring clinical trial NCT04844359?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04844359 being conducted?
This trial has 7 study locations across Arizona, California, Colorado, Illinois, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypersensitivity Pneumonitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.